Viatris Inc (VTRS)
11.62
+0.16
(+1.44%)
USD |
NASDAQ |
Nov 05, 16:00
11.60
-0.02
(-0.17%)
After-Hours: 18:30
Viatris Market Cap: 13.87B for Nov. 5, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 04, 2024 | 13.67B |
| November 01, 2024 | 13.87B |
| October 31, 2024 | 13.85B |
| October 30, 2024 | 14.19B |
| October 29, 2024 | 14.01B |
| October 28, 2024 | 14.04B |
| October 25, 2024 | 13.65B |
| October 24, 2024 | 13.70B |
| October 23, 2024 | 13.79B |
| October 22, 2024 | 13.93B |
| October 21, 2024 | 13.81B |
| October 18, 2024 | 14.04B |
| October 17, 2024 | 13.98B |
| October 16, 2024 | 14.11B |
| October 15, 2024 | 14.13B |
| October 14, 2024 | 13.60B |
| October 11, 2024 | 13.58B |
| October 10, 2024 | 13.52B |
| October 09, 2024 | 13.62B |
| October 08, 2024 | 13.51B |
| October 07, 2024 | 13.52B |
| October 04, 2024 | 13.83B |
| October 03, 2024 | 13.64B |
| October 02, 2024 | 13.69B |
| October 01, 2024 | 13.71B |
| Date | Value |
|---|---|
| September 30, 2024 | 13.86B |
| September 27, 2024 | 13.79B |
| September 26, 2024 | 13.87B |
| September 25, 2024 | 13.45B |
| September 24, 2024 | 13.67B |
| September 23, 2024 | 13.69B |
| September 20, 2024 | 13.59B |
| September 19, 2024 | 14.20B |
| September 18, 2024 | 14.20B |
| September 17, 2024 | 14.11B |
| September 16, 2024 | 14.10B |
| September 13, 2024 | 13.92B |
| September 12, 2024 | 14.02B |
| September 11, 2024 | 13.53B |
| September 10, 2024 | 13.33B |
| September 09, 2024 | 13.28B |
| September 06, 2024 | 13.45B |
| September 05, 2024 | 13.93B |
| September 04, 2024 | 14.06B |
| September 03, 2024 | 14.19B |
| August 30, 2024 | 14.42B |
| August 29, 2024 | 14.19B |
| August 28, 2024 | 14.20B |
| August 27, 2024 | 13.95B |
| August 26, 2024 | 14.02B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
6.845B
Minimum
Mar 12 2020
22.62B
Maximum
Dec 31 2020
13.32B
Average
13.15B
Median
May 12 2022
Market Cap Benchmarks
| Lexicon Pharmaceuticals Inc | 428.37M |
| Eli Lilly and Co | 765.50B |
| Amgen Inc | 171.60B |
| Gilead Sciences Inc | 112.30B |
| Perspective Therapeutics Inc | 832.06M |
Market Cap Related Metrics
| PS Ratio | 0.9186 |
| Price to Book Value | 0.7105 |
| Price to Free Cash Flow | 7.431 |
| Price | 11.62 |
| Earnings Yield | -4.73% |
| Operating PE Ratio | 36.40 |